Position in RNXT
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$4,317,329
+$574,071 QoQ
Shares Held
4,405,439
+18.9% QoQ
Ownership
9.76%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#1
of 28 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 69%
Shared 31%
None 0%
Common Shares in RNXT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AIGH Capital Management LLC holds $149,698,985 across 14 Biotechnology names. RNXT ranks #10 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | FENC |
Fennec Pharmaceuticals Inc.
|
2,486,038 | $26,724,908 | |
| 2 | KYTX |
Kyverna Therapeutics, Inc.
|
2,795,797 | $24,910,550 | |
| 3 | ABEO |
Abeona Therapeutics Inc.
|
2,987,000 | $18,459,660 | |
| 4 | ARDX |
Ardelyx, Inc.
|
3,200,000 | $16,319,999 | |
| 5 | SPRB |
Spruce Biosciences, Inc.
|
250,000 | $13,500,000 | |
| 6 | VNDA |
Vanda Pharmaceuticals Inc.
|
2,044,169 | $12,510,313 | |
| 7 | PTHS |
Pelthos Therapeutics Inc.
|
329,098 | $9,300,309 | |
| 8 | PYPD |
PolyPid Ltd.
|
1,504,741 | $7,644,084 |
All Filings in RNXT
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,317,329 | 4,405,439 | Shares | Other | 2026-08-07 | |
| 2026-03-31 | $3,743,258 | 3,706,197 | Shares | Other | 2026-04-30 | |
| 2025-12-31 | $2,380,470 | 2,833,894 | Shares | Other | 2026-02-02 | |
| 2025-09-30 | $3,321,295 | 2,615,193 | Shares | Other | 2025-10-31 | |
| 2025-06-30 | $4,559,466 | 3,467,275 | Shares | Other | 2025-07-29 | |
| 2025-03-31 | $3,432,601 | 3,467,275 | Shares | Other | 2025-05-06 | |
| No filing history on record for this holder in this stock. | ||||||